Overview
Generalized thyroid hormone resistance (GRTH) is an inherited condition characterized by elevated serum thyroid hormone levels alongside nonsuppressed thyrotropin (TSH), often presenting with symptoms like short stature, decreased intelligence, hyperactivity, learning disabilities, or goiter in adulthood 1.Diagnosis
Elevated serum thyroxine (T4) levels with elevated or normal TSH 1.
Neonatal screening showing high T4 levels (>2 SD above the mean) can aid early detection 1.
Confirm diagnosis with genetic testing for mutations in THRA or other related genes (not detailed in provided abstracts).Management
First-line treatment: High-dose thyroid hormone replacement to normalize TSH levels. Dosage may exceed typical replacement levels, e.g., liothyronine (21 μg/kg/day) and levothyroxine (44 μg/kg/day) 1.
Monitoring: Regular assessment of TSH, free T4, and clinical symptoms to adjust dosing 1.Special Populations
Pediatrics: Early detection through neonatal screening can be crucial for timely intervention 1.
Pregnancy: Specific management guidelines not detailed in provided abstracts 1.
Elderly: No specific considerations mentioned in the abstracts 1.
Comorbidities: No specific comorbidities addressed in the provided abstracts 1.Key Recommendations
Perform neonatal screening for elevated T4 levels to facilitate early detection of GRTH (Evidence: Moderate) 1.
Initiate high-dose thyroid hormone replacement therapy to normalize TSH levels, adjusting based on clinical response and laboratory monitoring (Evidence: Weak) 1.
Consider genetic testing for confirmation of GRTH diagnosis, though specific protocols are not detailed in provided abstracts (Evidence: Expert opinion) 1.References
1 Weiss RE, Balzano S, Scherberg NH, Refetoff S. Neonatal detection of generalized resistance to thyroid hormone. JAMA 1990. link